Outcome of anti-PL12 positive patients with antisynthetase syndrome

Presse Medicale

Volumn 42, Issue 6 PART1, 2013, Pages

  Marie, Isabelle ^a   Josse, Séverine ^a   Decaux, Olivier ^b   Dominique, Stéphane ^c   Landron, Cédric ^d   Roblot, Pascal ^d   Jouneau, Stéphane ^b   Vittecoq, Olivier ^c   Jouen, Fabienne ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b RENNES UNIVERSITY HOSPITAL   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

^d POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CARBON MONOXIDE; PL12 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTISYNTHETASE SYNDROME; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ESOPHAGUS DISEASE; FEMALE; FOLLOW UP; FORCED VITAL CAPACITY; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL HEMORRHAGE; HAND DISEASE; HUMAN; IMMUNOBLOTTING; INTERSTITIAL LUNG DISEASE; LUNG DIFFUSION CAPACITY; MALE; MECHANIC HAND; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; PHENOTYPIC VARIATION; PNEUMONIA; POLYMYOSITIS; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; SKIN CALCIFICATION; VITAL CAPACITY; WESTERN BLOTTING;

EID: 84879253850     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2012.12.003     Document Type: Article

References (25)

1. Marguerie C., Bunn C.C., Beynon H.L., Bernstein R.M., Hughes J.M., So A.K., et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990, 77:1019-1038.
2. Marie I., Dominique S., Janvresse A., Levesque H., Menard J.F. Rituximab therapy for refractory interstitial lung disease related to antisynthetase syndrome. Respir Med 2012, 106:581-587.
3. Marie I., Hatron P.Y., Dominique S., Cherin P., Mouthon L., Menard J.F., et al. Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody. Semin Arthritis Rheum 2012, 41:890-899.
4. Koenig M., Fritzler M.J., Targoff I.N., Troyanov Y., Senecal J.L. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res Ther 2007, 9:R78.
5. Marie I., Menard J.F., Hatron P.Y., Hachulla E., Mouthon L., Tiev K., et al. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients. Arthritis Care Res 2010, 62:1748-1755.
6. Marie I., Hatron P.Y., Dominique S., Cherin P., Mouthon L., Menard J.F. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum 2011, 63:3439-3447.
7. Quanjer P.H. Clinical respiratory physiology: standardized lung function testing: working party report: standardization of lung function tests. Bull Eur Physiopathol Respir 1983, 19(Suppl.5):1-95.
8. Marie I., Josse S., Hatron P.Y., Dominique S., Hachulla E., Janvresse A., et al. Interstitial lung disease in anti-jo1 patients with antisynthetase syndrome. Arthritis Care Res 2012, [Epub ahead of print]. 10.1002/acr.21895.
9. Bunn C.C., Bernstein R.M., Mathews M.B. Autoantibodies against alanyl-tRNA synthetase and tRNA-Ala coexist and are associated with myositis. J Exp Med 1986, 163:1281-1291.
10. Dugar M., Cox S., Limaye V., Blumbergs P., Roberts-Thomson P.J. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies. Intern Med J 2011, 41:674-679.
11. Fischer A., Swigris J.J., du Bois R.M., Lynch D.A., Downey G.P., Cosgrove G.P., et al. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir Med 2009, 103:1719-1724.
12. Handa T., Nagai S., Kawabata D., Nagao T., Takemura M., Kitaichi M., et al. Long-term clinical course of a patient with anti PL-12 antibody accompanied by interstitial pneumonia and severe pulmonary hypertension. Intern Med 2005, 44:319-325.
13. Hervier B., Devilliers H., Stanciu R., Meyer A., Uzunhan Y., Masseau A., et al. Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev 2012, 12:210-217.
14. Hervier B., Wallaert B., Hachulla E., Adoue D., Lauque D., Audrain M., et al. Clinical manifestations of anti-synthetase syndrome positive for anti-alanyl-tRNA synthetase (anti-PL12) antibodies: a retrospective study of 17 cases. Rheumatology (Oxford) 2010, 49:972-976.
15. Kalluri M., Sahn S.A., Oddis C.V., Gharib S.L., Christopher-Stine L., Danoff S.K., et al. Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature. Chest 2009, 135:1550-1556.
16. Marie I., Josse S., Decaux O., Dominique S., Diot E., Landron C., et al. Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 2012, 11:739-745.
17. Satoh S., Hirakata M., Suwa A., Mimori T., Inada S., Akizuki M. Two cases of interstitial pneumonia with anti-PL-12 (alanyl tRNA synthetase) antibodies. Ryumachi 1996, 36:862-868.
18. Yoshifuji H., Fujii T., Kobayashi S., Imura Y., Fujita Y., Kawabata D., et al. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 2006, 39:233-241.
19. Casciola-Rosen L., Mammen A.L. Myositis autoantibodies. Curr Opin Rheumatol 2012, 24:602-608.
20. Targoff I.N. Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol 1993, 100:116S-123S.
21. Love L.A., Leff R.L., Fraser D.D., Targoff I.N., Dalakas M., Plotz P.H., et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991, 70:360-374.
22. Mimori T., Imura Y., Nakashima R., Yoshifuji H. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol 2007, 19:523-529.
23. Sordet C., Goetz J., Sibilia J. Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. Joint Bone Spine 2006, 73:646-654.
24. Targoff I.N., Arnett F.C. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med 1990, 88:241-251.
25. Marie I., Mouthon L. Therapy of polymyositis and dermatomyositis. Autoimmun Rev 2011, 11:6-13.